Abstrakt

Przypisy

• 1. Breitwieser G.E.: G protein-coupled receptor oligomerization:implications for G protein activation and cell signaling. Circ. Res.,2004; 94: 17-27
  Google Scholar
• 2. Budzyn K., Marley P.D., Sobey C.G.: Targeting Rho and Rho-kinasein the treatment of cardiovascular disease. Trends Pharmacol. Sci.,2006; 27: 97-104
  Google Scholar
• 3. Büssemaker E., Pistrosch F., Förster S., Herbrig K., Gross P., PassauerJ., Brandes R.P.: Rho kinase contributes to basal vascular tonein humans: role of endothelium-derived nitric oxide. Am. J. Physiol.Heart Circ. Physiol., 2007; 293: H541-H547
  Google Scholar
• 4. Chapados R., Abe K., Ihida-Stansbury K., McKean D., Gates A.T.,Kern M., Merklinger S., Elliott J., Plant A., Shimokawa H., Jones P.L.:ROCK controls matrix synthesis in vascular smooth muscle cells:coupling vasoconstriction to vascular remodeling. Circ. Res., 2006;99: 837-844
  Google Scholar
• 5. Che Q., Carmines P.K.: Src family kinase involvement in rat preglomerularmicrovascular contractile and [Ca2+]i responses to ANGII. Am. J. Physiol. Renal Physiol., 2005; 288: F658-F664
  Google Scholar
• 6. Drake M.T., Shenoy S.K., Lefkowitz R.J.: Trafficking of G proteincoupledreceptors. Circ. Res., 2006; 99: 570-582
  Google Scholar
• 7. Friel A.M., Sexton D.J., O’reilly M.W., Smith T.J., Morrison J.J.: RhoA/Rho kinase: human umbilical artery mRNA expression in normaland pre eclamptic pregnancies and functional role in isoprostaneinducedvasoconstriction. Reproduction, 2006; 132: 169-176
  Google Scholar
• 8. Ganesan L.P., Joshi T., Fang H., Kutala V.K., Roda J., Trotta R.,Lehman A., Kuppusamy P., Byrd J.C., Carson W.E., Caligiuri M.A., TridandapaniS.: FcγR-induced production of superoxide and inflammatorycytokines is differentially regulated by SHIP through its influenceon PI3K and/or Ras/Erk pathways. Blood, 2006; 108: 718-725
  Google Scholar
• 9. Ganguli A., Persson L., Palmer I.R., Evans I., Yang L., SmallwoodR., Black R., Qwarnstrom E.E.: Distinct NF-κB regulation by shearstress through Ras-dependent IκBα oscillations: real-time analysisof flow-mediated activation in live cells. Circ. Res., 2005; 96: 626-634
  Google Scholar
• 10. Hilgers R.H., Webb R.C.: Molecular aspects of arterial smoothmuscle contraction: focus on Rho. Exp. Biol. Med., 2005; 230: 829-835
  Google Scholar
• 11. Ishizaki T., Uehata M., Tamechika I., Keel J., Nonomura K., MaekawaM., Narumiya S.: Pharmacological properties of Y-27632 a specificinhibitor of rho-associated kinases. Mol. Pharmacol., 2000; 57:976-983
  Google Scholar
• 12. Keef K.D., Hume J.R., Zhong J.: Regulation of cardiac and smoothmuscle Ca2+ channels (Cav1.2a,b) by protein kinases. Am. J. Physiol.Cell Physiol., 2001; 281: C1743-C1756
  Google Scholar
• 13. Kenakin T.: Principles: receptor theory in pharmacology. TrendsPharmacol. Sci., 2004; 25: 186-192
  Google Scholar
• 14. Kenakin T., Jenkinson S., Watson C.: Determining the potencyand molecular mechanism of action of insurmountable antagonists.J. Pharmacol. Exp. Ther., 2006; 319: 710-723
  Google Scholar
• 15. Kimura K., Ito M., Amano M., Chihara K., Fukata Y., Nakafuku M.,Yamamori B., Feng J., Nakano T., Okawa K., Iwamatsu A., KaibuchiK.: Regulation of myosin phosphatase by Rho and Rho-associatedkinase (Rho-kinase). Science, 1996; 273: 245-248
  Google Scholar
• 16. Laufs U., Liao J.K.: Targeting Rho in cardiovascular disease. Circ.Res., 2000; 87: 526-528
  Google Scholar
• 17. Lee D.L., Webb R.C., Jin L.: Hypertension and RhoA/Rho-kinasesignaling in the vasculature: highlights from the recent literature.Hypertension, 2004; 44: 796-799
  Google Scholar
• 18. Lin K., Wang D., Sadée W.: Serum response factor activation bymuscarinic receptors via RhoA novel pathway specific to M1 subtypeinvolving calmodulin calcineurin and Pyk2. J. Biol. Chem., 2002;277: 40789-40798
  Google Scholar
• 19. Loirand G., Guerin P., Pacaud P.: Rho kinases in cardiovascularphysiology and pathophysiology. Circ. Res., 2006; 98: 322-334
  Google Scholar
• 20. Mehta P.K., Griendling K.K.: Angiotensin II cell signaling: physiologicaland pathological effects in the cardiovascular system. Am.J. Physiol. Cell. Physiol., 2007; 292: C82-C97
  Google Scholar
• 21. Ohtsu H., Dempsey P.J., Eguchi S.: ADAMs as mediators of EGFreceptor transactivation by G protein-coupled receptors. Am. J. Physiol.Cell Physiol., 2006; 291: C1–C10
  Google Scholar
• 22. Ohtsu H., Mifune M., Frank G.D., Saito S., Inagami T., Kim-MitsuyamaS., Takuwa Y., Sasaki T., Rothstein J.D., Suzuki H., NakashimaH., Woolfolk E.A., Motley E.D., Eguchi S.: Signal-crosstalk betweenRho/ROCK and c-Jun NH2-terminal kinase mediates migration ofvascular smooth muscle cells stimulated by angiotensin II. Arterioscler.Thromb. Vasc. Biol., 2005; 25: 1831-1836
  Google Scholar
• 23. Ratz P.H., Berg K.M., Urban N.H., Miner A.S.: Regulation of smoothmuscle calcium sensitivity: KCl as a calcium-sensitizing stimulus.Am. J. Physiol. Cell Physiol., 2005; 288: C769-C783
  Google Scholar
• 24. Rikitake Y., Liao J.K.: ROCKs as therapeutic targets in cardiovasculardiseases. Expert Rev. Cardiovasc. Ther., 2005; 3: 441-451
  Google Scholar
• 25. Shiga N., Hirano K., Hirano M., Nishimura J., Nawata H., KanaideH.: Long-term inhibition of RhoA attenuates vascular contractilityby enhancing endothelial NO production in an intact rabbit mesentericartery. Circ. Res., 2005; 96: 1014-1021
  Google Scholar
• 26. Shimokawa H., Takeshita A.: Rho-kinase is an important therapeutictarget in cardiovascular medicine. Arterioscler. Thromb.Vasc. Biol., 2005; 25: 1767-1775
  Google Scholar
• 27. Slupski M., Szadujkis-Szadurski L., Grześk G., Szadujkis-SzadurskiR., Szadujkis-Szadurska K., Wlodarczyk Z., Masztalerz M., PiotrowiakI., Jasiński M.: Guanylate cyclase activators influence reactivity ofhuman mesenteric superior arteries retrieved and preserved in thesame conditions as transplanted kidneys. Transplant. Proc., 2007;39: 1350-1353
  Google Scholar
• 28. Somlyo A.P., Somlyo A.V.: Ca2+-sensitivity of smooth and non–muscle myosin II: modulation by G proteins kinases and myosinphosphatase. Physiol. Rev., 2003; 83: 1325-1358
  Google Scholar
• 29. Szadujkis-Szadurska K., Slupski M., Szadujkis-Szadurski R., JasinskiM., Grześk G., Matusiak G.: Modulation of the reaction of vascularsmooth muscle cells to angiotensin II induced by catalaseand aminotriasol during ischemia-reperfusion. Transplant. Proc.,2010; 42: 1614-1617
  Google Scholar
• 30. Szadujkis-Szadurska K., Slupski M., Szadujkis-Szadurski R., Szadujkis-SzadurskiL., Jasiñski M., Kolodziejska R.: The role of the endotheliumin the regulation of vascular smooth muscle cell contractionsinduced by angiotensin II after ischemia and reperfusion.Arch. Pharm. Res., 2010; 33: 1019-1024
  Google Scholar
• 31. Szadujkis-Szadurska K., Szadujkis-Szadurski L., Szadujkis-SzadurskiR., Grześk G.: Modulation of the reactivity of the vascularsmooth muscle cells on angiotensin II (ANG II) during ischemia/reperfusion (I/R). Eur. J. Clin. Invest., 2006; 36, suppl. 1: 4
  Google Scholar
• 32. Szadujkis-Szadurski L., Szadujkis-Szadurski R., Szadujkis-SzadurskaK., Skublicki S., Szymański W.: Nitric oxide induces dilationof human chorionic via inhibition of Rho-kinase signalling. Fund.Clin. Pharmacol., 2004; 18, suppl. 1: 77
  Google Scholar
• 33. Szadujkis-Szadurski R., Szadujkis-Szadurska K., Szadujkis-SzadurskiL., Skublicki S., Szymański W.: Angiotensin II-evoked Ca2+ releaseand influx responses are inhibited by nitric oxide in humanchorionic arteries. Pol. J. Pharmacol., 2004; 56, suppl.: 199
  Google Scholar
• 34. Thompson-Torgerson C.S., Holowatz L.A., Flavahan N.A., KenneyW.L.: Cold-induced cutaneous vasoconstriction is mediated by Rhokinase in vivo in human skin. Am. J. Physiol. Heart Circ. Physiol.,2007; 292: H1700-H1705
  Google Scholar
• 35. Uehata M., Ishizaki T., Satoh H., Ono T., Kawahara T., MorishitaT., Tamakawa H., Yamagami K., Inui J., Maekawa M., Narumiya S.:Calcium sensitization of smooth muscle mediated by a Rho-associatedprotein kinase in hypertension. Nature, 1997; 389: 990-994
  Google Scholar
• 36. Volpe M., Tocci G., Savoia C.: Angiotensin II receptor blockersand coronary artery disease: ‘presumed innocents’. Eur. Heart J.,2006; 27: 1506-1507
  Google Scholar
• 37. Wang Q.S., Zheng Y.M., Dong L., Ho Y.S., Guo Z., Wang Y.X.: Roleof mitochondrial reactive oxygen species in hypoxia-dependent increasein intracellular calcium in pulmonary artery myocytes. FreeRadic. Biol. Med., 2007; 42: 642-653
  Google Scholar
• 38. Wang Z., Jin N., Ganguli S., Swartz D.R., Li L., Rhoades R.A.: Rho–kinase activation is involved in hypoxia-induced pulmonary vasoconstriction.Am. J. Respir. Cell Mol. Biol., 2001; 25: 628-635
  Google Scholar
• 39. Yin J., Jin L., Ying Z., Webb R.C.: Activation of NADPH oxidasecontributes to RhoA/Rho-kinase dependent contraction induced byangiotensin II. Hypertension, 2004; 44: 560
  Google Scholar

Pełna treść artykułu